Cargando…

Interferon alpha: recently approved in a number of countries for use in hairy cell leukaemia and/or Kaposi's sarcoma

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7149213/
http://dx.doi.org/10.1007/BF03307505
_version_ 1783520763412742144
collection PubMed
description
format Online
Article
Text
id pubmed-7149213
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-71492132020-04-13 Interferon alpha: recently approved in a number of countries for use in hairy cell leukaemia and/or Kaposi's sarcoma InPharma Newsletter Article Springer International Publishing 2013-02-19 1986 /pmc/articles/PMC7149213/ http://dx.doi.org/10.1007/BF03307505 Text en © Adis International Ltd 1986 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Newsletter Article
Interferon alpha: recently approved in a number of countries for use in hairy cell leukaemia and/or Kaposi's sarcoma
title Interferon alpha: recently approved in a number of countries for use in hairy cell leukaemia and/or Kaposi's sarcoma
title_full Interferon alpha: recently approved in a number of countries for use in hairy cell leukaemia and/or Kaposi's sarcoma
title_fullStr Interferon alpha: recently approved in a number of countries for use in hairy cell leukaemia and/or Kaposi's sarcoma
title_full_unstemmed Interferon alpha: recently approved in a number of countries for use in hairy cell leukaemia and/or Kaposi's sarcoma
title_short Interferon alpha: recently approved in a number of countries for use in hairy cell leukaemia and/or Kaposi's sarcoma
title_sort interferon alpha: recently approved in a number of countries for use in hairy cell leukaemia and/or kaposi's sarcoma
topic Newsletter Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7149213/
http://dx.doi.org/10.1007/BF03307505